Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S18, 2018. DOI: 10.25251/skin.2.supp.18. Disponível em: https://skin.dermsquared.com/skin/article/view/297. Acesso em: 19 apr. 2025.